Peptide Referee

SLU-PP-332: research, legal status and who sells it

This page is information, not medical advice. SLU-PP-332 is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.

Category
Synthetic estrogen-related receptor (ERR) agonist studied as an exercise mimetic (not a peptide)
Evidence level
Preclinical (lab and animal studies)
Price range
$4.00/mg to $32.00/mg, median $15.60/mg across 18 vendors (compare)
Our lab tests
None yet (how testing will work)
WhereStatus
United StatesNo FDA-approved drug contains SLU-PP-332 [1].
United KingdomNo UK-licensed medicine containing SLU-PP-332 appears in the MHRA products database [2].
European UnionNo medicine containing SLU-PP-332 is authorized in the EU, according to EMA's central and Article 57 product data [3][4].
CanadaNo product containing SLU-PP-332 appears in Health Canada's Drug Product Database [5].
AustraliaSLU-PP-332 is not named in Australia's Poisons Standard (October 2026) [6].
Sport (WADA)Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7].
 Summaries of official sources, checked —. Rules change; follow the source links. Not legal advice.

We haven't published a full overview of SLU-PP-332 yet. The legal status table and live prices on this page are current.

SLU-PP-332 prices: cheapest listings

The five lowest $/mg listings out of 23. See all SLU-PP-332 prices

Vendor Transparency Product Size Price $/mg vs median Stock Vendor's page
Bulk Peptide Wholesale 45/100* SLU-PP-332 5 mg (10 vials) 5 mg × 10 $200 $4.00/mg −74% In stock View
Bulk Peptide Supply 57/100* SLU-PP-332 5 mg 5 mg $30 $6.00/mg −62% In stock View
Bulk Peptide Supply 57/100* SLU-PP-332 5 mg (10 vials) 5 mg × 10 $325 $6.50/mg −58% In stock View
Apex Amino 55/100 SLU-PP-332 – 10mg 10 mg $85 $8.50/mg −46% In stock View
Pure Peptide Labs 90/100 SLU-PP-332 5 mg $45 $8.99/mg −42% Out of stock View

Prices come from each vendor's public product feed and were last fetched Oct 15, 2026. They exclude shipping and discounts. $/mg uses the labeled amount, not measured content. A transparency score marked * is based on fewer than six checks; checks we couldn't complete score 0. How we compare prices.

Sources

  1. Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
  2. MHRA Products: licensed-medicine search for "slu-pp-332". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
  3. EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
  4. EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
  5. Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
  6. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
  7. World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
  8. A Synthetic ERR Agonist Alleviates Metabolic Syndrome. Journal of Pharmacology and Experimental Therapeutics (2024). Accessed Oct 15, 2026
  9. Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes. Drug Testing and Analysis (2026). Accessed Oct 15, 2026